SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink Hard-to-Treat head and neck tumors
Disease control Not yet recruitingThis study tests whether adding fianlimab to standard cemiplimab and chemotherapy can better shrink advanced head and neck cancers in adults with HPV-positive disease. About 90 participants will receive either the two-drug or three-drug combination before radiation. The goal is t…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo aims to tame head and neck cancer
Disease control Not yet recruitingThis study tests a combination of the immunotherapy drug toripalimab with two chemotherapy drugs (cisplatin and docetaxel) as an initial treatment for people with advanced head and neck cancer that has a specific marker (CPS-positive). The goal is to see if this combination is sa…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Blood test may let HPV throat cancer patients avoid radiation
Disease control Not yet recruitingThis study looks at whether people with HPV-related throat cancer can safely skip radiation after surgery if a blood test two weeks later shows no signs of cancer. About 36 patients will have robotic surgery and then be monitored with regular checkups and blood tests. The goal is…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New radiation treatment shows promise for skin cancer in vulnerable patients
Disease control Not yet recruitingThis study is testing a new type of radiation therapy, called Alpha DaRT, for people with a common skin cancer (squamous cell carcinoma) who have weakened immune systems. The treatment is given directly into the tumor. The goal is to see if it can shrink or control the cancer for…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Vitamin d and light therapy: a new hope for skin cancer?
Knowledge-focused Not yet recruitingThis study looks at whether taking vitamin D before a light-based treatment (photodynamic therapy, or PDT) can help the immune system fight nonmelanoma skin cancer. About 54 adults scheduled for skin cancer surgery will take either vitamin D or a placebo for 6 days, then receive …
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC